Make your money go further for just 25p per day

Cello Group plc (AIM:CLL) – numbers look encouraging but tough to understand their offering

19/03/2015 · Cello Group plc (CLL) 

The pharmaceutical and consumer strategic marketing group announced decent final audited results for the year to 31 December 2014. It’s quite tough for an outsider to fully understand what this business does but the numbers look quite encouraging!

Cello is a partnership of professionals that delivers specialist solutions primarily to the pharmaceutical and health sectors, as well as other high margin client industries. The Group operate through two companies; Cello Health and Cello Signal.

Cello delivers its services from office networks in the UK, USA, Singapore and Hong Kong, through a group of over 800 professionals.

2014 saw a strong financial and operational performance from the Group. For the year ending…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Cello Group plc

Coronavirus impact: 7 April - dividend commitments including a reliable 10% yield

07/04/2020 · Company Insights

We commented last week how CMC Markets is benefitting from the stock market volatility and another…


Cello Group plc (AIM:CLL) – numbers look encouraging but tough to understand their offering

19/03/2015 · Company Insights
The pharmaceutical and consumer strategic marketing group announced decent final audited results for the year to…

More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP